Competition is coming for a top drug

from POLITICO's Pulse Check · host POLITICO

Today in our Pulse Check podcast, Lauren Gardner talks with Megan Messerly about the introduction of biosimilars next year to compete with Humira, the anti-inflammatory used to treat arthritis that has been the best-selling drug in America. Competition could reduce prices for consumers, but that’s not certain. Lauren explains how it could play out. Learn more about your ad choices. Visit megaphone.fm/adchoices

Episode metadata supplied by the publisher feed · Published Dec 12, 2022

Embed this episode

Attribution link and audio player

NOW PLAYING

Competition is coming for a top drug

0:00 10:28

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

#205 How to recover without burning out: using pacing to find your dehoarding rhythm

Nov 22, 2025 ·38m

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of POLITICO's Pulse Check?

This episode is 10 minutes long.

When was this POLITICO's Pulse Check episode published?

This episode was published on December 12, 2022.

Can I download this POLITICO's Pulse Check episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!